RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
  Drug Delivery
  Nanotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Biotechnology Channel

subscribe to Biotechnology newsletter
Latest Research : Biotechnology

   EMAIL   |   PRINT
Biotech failed to meet promises

Oct 14, 2005 - 9:43:00 PM
The promises of biotechnology substances to be more effective and less toxic than conventional drugs have been only partially fulfilled, they add. Many of the substances produced so far are analogues of existing drugs and have contributed little to innovation in medicine.

 
[RxPG] Promises of cheaper and better drugs using biotechnologies have not been met, say researchers in this week’s BMJ. They assessed biotech products approved by the European Medicine Evaluation Agency between 1995 and 2003.

Of 61 products licensed for therapeutic use, only 15 were for diseases without effective treatment, more effective than existing treatment, or active in patients resistant to current treatment.

A further 22 offered limited advantages over existing products, and 24 were copycat drugs, many of which have failed to offer new options for patients and provide no cost advantage, say the authors.

Furthermore, evaluation of these substances was not always based on rigorous methodological criteria, suggesting that commercial priorities come before the sound development of drugs in the interest of patients.

The promises of biotechnology substances to be more effective and less toxic than conventional drugs have been only partially fulfilled, they add. Many of the substances produced so far are analogues of existing drugs and have contributed little to innovation in medicine.

Nevertheless, biotechnology has made it possible to make available drugs that would otherwise be impossible to obtain in large amounts or research tools that are useful for discovering new drugs. “Let us hope that in future biotechnology will better live up to its promises.”



Publication: British Medical Journal Issue Dated 15 October 2005 (Vol 331, No 7521)
On the web: Read full text article on http://bmj.com 

Advertise in this space for $10 per month. Contact us today.


Related Biotechnology News
Synthetic protein to help regenerate new tissues
Nanostructures lend cutting edge to antibiotics
Nanoparticles could offer relief from rashes
Carbon nanotubes can affect lung lining
Chicken egg whites - answer to three-dimensional cell culture systems
Nanoparticles hitchhike on red blood cells for drug delivery
Gold Nanoparticle Molecular Ruler to Measure Smallest of Life’s Phenomena
Tiny inhaled particles take easy route from nose to brain
DNA Amplification and Detection Made Simple
Solitons Could Power Artificial Muscles

Subscribe to Biotechnology Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)